EDMONTON, AB, May 3, 2022
/PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora")
(NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future
of cannabinoids worldwide, announced today that it has scheduled a
conference call to discuss the results for its third quarter fiscal
year 2022 on Thursday, May 12, 2022
at 5:00 p.m. Eastern Time |
3:00 p.m. Mountain Time. The Company
will report its financial results for the third quarter fiscal year
2022 after the close of markets that same day.
Conference Call Details
|
DATE:
|
Thursday, May 12,
2022
|
|
TIME:
|
5:00 p.m. Eastern Time
| 3:00 p.m. Mountain Time
|
|
WEBCAST:
|
Click here
|
Miguel Martin, Chief Executive
Officer, and Glen Ibbott, Chief
Financial Officer, will host the conference call and question and
answer period. This weblink has also been posted to the Company's
"Investor Info" link at https://investor.auroramj.com/ under "News
& Events".
About Aurora
Aurora is a global leader in the cannabis industry, serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Aurora Drift, San
Rafael '71, Daily Special, and Whistler, as well as CBD brands,
Reliva and KG7. Medical cannabis brands include MedReleaf,
CanniMed, Aurora, Whistler Medical Marijuana Co, and Pedanios.
Driven by science and innovation, and with a focus on high-quality
cannabis products, Aurora's brands continue to break through as
industry leaders in the medical, performance, wellness and adult
recreational markets wherever they are launched. Learn more at
www.auroramj.com and follow us on Twitter and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB" and is a constituent of the S&P/TSX Composite
Index.
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include statements regarding timing of the release of the
Company's financial statements for third quarter ended March
31, 2022 and scheduling of the conference call to discuss
results.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions managements considers to
be reasonable. Material factors or assumptions involved in
developing forward-looking statements include, without limitation,
publicly available information from governmental sources as well as
from market research and industry analysis and on assumptions based
on data and knowledge of this industry which the Company believes
to be reasonable. Forward-looking statements are subject to a
variety of risks, uncertainties and other factors that management
believes to be relevant and reasonable in the circumstances could
cause actual events, results, level of activity, performance,
prospects, opportunities or achievements to differ materially from
those projected in the forward-looking statements. These risks
include, but are not limited to, the ability to retain key
personnel, the ability to continue investing in infrastructure to
support growth, the ability to obtain financing on acceptable
terms, the continued quality of our products, customer experience
and retention, the development of third party government and
non-government consumer sales channels, management's
estimates of consumer demand in Canada and in
jurisdictions where the Company exports, expectations of future
results and expenses, the risk of successful integration of
acquired business and operations, management's estimation that
SG&A will grow only in proportion of revenue growth, the
ability to expand and maintain distribution capabilities, the
impact of competition, the general impact of financial market
conditions, the yield from cannabis growing operations, product
demand, changes in prices of required commodities, competition, and
the possibility for changes in laws, rules, and regulations in the
industry, epidemics, pandemics or other public health crises,
including the current outbreak of COVID-19, and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 27,
2021 (the "AIF") and filed with Canadian securities regulators
available on the Company's issuer profile on SEDAR
at www.sedar.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that
the list of risks, uncertainties and other factors described in the
AIF is not exhaustive and other factors could also adversely affect
its results. Readers are urged to consider the risks, uncertainties
and assumptions carefully in evaluating the forward-looking
statements and are cautioned not to place undue reliance on such
information. The Company is under no obligation, and expressly
disclaims any intention or obligation, to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as expressly required by
applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-third-quarter-fiscal-year-2022-investor-conference-call-301538965.html
SOURCE Aurora Cannabis Inc.